Form 8-K - Current report:
SEC Accession No. 0000950170-25-114530
Filing Date
2025-09-12
Accepted
2025-09-12 16:11:51
Documents
10
Period of Report
2025-09-10
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K bntc-20250910.htm   iXBRL 8-K 50774
  Complete submission text file 0000950170-25-114530.txt   153787

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bntc-20250910.xsd EX-101.SCH 23883
12 EXTRACTED XBRL INSTANCE DOCUMENT bntc-20250910_htm.xml XML 4509
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 251311628
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)